GoldenGolden
Advanced Search
EpiBone

EpiBone

EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.

All edits

Edits on 11 Jun, 2021
Erin Scherfner"prospector:321:158727"
Erin Scherfner edited on 11 Jun, 2021
Edits made to:
Infobox (+3 properties)
Infobox
Country
United States
Edits on 11 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 11 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 29 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Edits on 16 Nov, 2020
Carla Faraguna
Carla Faraguna edited on 16 Nov, 2020
Edits made to:
Timeline (+1 events) (+98/-21 characters)
Timeline

November 16, 2020

EpiBone announces the appointment of Robert S. Langer, Sc.D., to its Board of Directors.

May 22, 2019

EpiBone, Inc. today announcedannounces that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1/2 clinical trial of its lead bone product EpiBone-Craniomaxillofacial (EB-CMF), as a potential treatment for ramus continuity defects in the mandible.
Edits on 12 Aug, 2020
Lax Mariappan
Lax Mariappan edited on 12 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Founded date
2013
Edits on 1 Aug, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 30 Jul, 2020
Golden AI
Golden AI edited on 30 Jul, 2020
Edits made to:
Infobox (+1 properties)
Edits on 30 Jul, 2020
Aime Anne Nisay
Aime Anne Nisay edited on 30 Jul, 2020
Edits made to:
Infobox (+1 properties)
Edits on 2 Mar, 2020
Golden AI"Attach Wikidata entity ID"
Golden AI edited on 2 Mar, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Wikidata entity ID
Q25326597
Edits on 5 Nov, 2019
Kurt Madsen
Kurt Madsen approved a suggestion from Golden's AI on 5 Nov, 2019
Edits made to:
Article (+10/-10 characters)
Article

On October 1, 2016 EpiBone received a convertible note worth $560 thousand from Plum AlleyPlum Alley.

Edits on 30 Oct, 2019
Meredith Hanel
Meredith Hanel edited on 30 Oct, 2019
Edits made to:
Timeline (+1 events) (+312 characters)
Article (+945/-145 characters)
Categories (+1 topics)
Related Topics (+1 topics)
Article

EpiBone is a biotechnology company headquartered in New York City, New York that was founded in 2013 by Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig. EpiBone uses biomedicalCEO engineeringand toCo-Founder createNina individualizedTandon boneworked graftson usingheart aregeneration patientsfor ownher mesenchymalPhD, stemworked cellsat grownMcKinsey inmanagement theconsultancy companiesand customhas builtan bioreactorMBA.

EpiBone uses a biomedical engineering process that includes 3D printing to create individualized bone grafts using a patients own mesenchymal stem cells grown in the company's custom built bioreactor. The process involves a CT scan to determine the exact size and shape of a needed bone. A precise, personalized scaffold is created. The patient’s stem cells are cultured so that they start becoming bone cells and are placed on the scaffold and remodel into a personalized bone graft that can be implanted.

Pipeline

Phase 1 and 2 clinical trial Investigational New Drug (IND) clearance was granted by the FDA in 2019 for their product EpiBone-Craniomaxillofacial (EB-CMF) as a treatment for ramus continuity defects in the mandible. The product is anatomically correct and manufactured from a patient’s own adipose derived stem cells.

Categories
Related Topics
Timeline

May 22, 2019

EpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1/2 clinical trial of its lead bone product EpiBone-Craniomaxillofacial (EB-CMF), as a potential treatment for ramus continuity defects in the mandible.
Edits on 3 Apr, 2019
Dawson Sewell
Dawson Sewell edited on 3 Apr, 2019
Edits made to:
Infobox (+6 properties)
Table (+1 rows) (+4 cells) (+145 characters)
Categories (-1 topics)
Related Topics (+1 topics)
Table

Title
Author
Link
Type

How a Bone-Growing Startup Lured 66 Investors, Including Peter Thiel

Liz Welch

Web

Infobox
Location
Industry
Date incorporated
2013
Categories
Related Topics
Edits on 21 Feb, 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 21 Feb, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 10 Jan, 2019
Golden AI
Golden AI edited on 10 Jan, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 10 Nov, 2018
Tianchang He
Tianchang He approved a suggestion from Golden's AI on 10 Nov, 2018
Edits made to:
Article (+11/-11 characters)
Article

EpiBone is a biotechnology company headquartered in New York City, New York that was founded in 2013 by Nina TandonNina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig. EpiBone uses biomedical engineering to create individualized bone grafts using a patients own mesenchymal stem cells grown in the companies custom built bioreactor.

Jude Gomila"Approved suggestion from source: http://www.epibone.com/"
Jude Gomila approved a suggestion from Golden's AI on 9 Nov, 2018
Edits made to:
Infobox (+1 properties)
Edits on 6 Nov, 2018
Dawson Sewell
Dawson Sewell edited on 6 Nov, 2018
Edits made to:
Description (+132/-6 characters)
Article (+622 characters)
Table (+9 rows) (+18 cells) (+286 characters)
Table (+1 rows) (+4 cells) (+138 characters)
Table (+2 rows) (+6 cells) (+219 characters)
Topic thumbnail

EpiBone

EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, inNew 2013York.

Article

EpiBone is a biotechnology company headquartered in New York City, New York that was founded in 2013 by Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig. EpiBone uses biomedical engineering to create individualized bone grafts using a patients own mesenchymal stem cells grown in the companies custom built bioreactor.

Funding
Grant

On June 12, 2014 EpiBone received an undisclosed amount of funding in the form of a grant from the Partnership Fund for New York City and Breakout Labs.

Convertible Note

On October 1, 2016 EpiBone received a convertible note worth $560 thousand from Plum Alley.

Table

Name
Role
Related Golden topics

Cato Laurencin

Advisor

Cliff Schorer

Advisor

Elma Hawkins

Chairman

Gordana Vunjak-Novakovic

Co-Founder & Chief Scientific Advisor

Hank Kucheman

Advisor

Henry Kravis

Advisor

Nina Tando

Co-Founder & CEO

Sarindr Bhumiratana

Co-Founder & CEO

Sidney Eisig

Co-Founder & Chief Clinical Advisor

Table

Title
Author
Link
Type

Why Peter Thiel Invested In New York Biotech Startup EpiBone

Liz Welch

News

Table

Title
Date
Link

Nina Tandon CEO and Co Founder EpiBone

May 17, 2018

Nina Tandon: Could tissue engineering mean personalized medicine?

December 6, 2018

Edits on 12 Sep, 2018
Carla Faraguna
Carla Faraguna edited on 12 Sep, 2018
Edits made to:
Categories (+1 topics)
Melanie Manipula
Melanie Manipula edited on 11 Sep, 2018
Edits made to:
Infobox (+4 properties)
Description (+138 characters)
Categories (+1 topics)
Related Topics (+2 topics)
Topic thumbnail

EpiBone

EpiBone is a biotechnology startup company developing bone reconstruction solutions. Nina Tandon founded EpiBone in New York City in 2013.

Infobox
Categories
Related Topics
Edits on 1 Jan, 2017
Golden AI"Initial topic creation"
Golden AI created this topic on 1 Jan, 2017
Edits made to:
Article
Topic thumbnail

 EpiBone

EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.